Expert Consensus on the Clinical Use of the Dapagliflozin–Pioglitazone Fixed-Dose Combination in Adults with Type 2 Diabetes Mellitus in India: PRO-3 Study
Type 2 diabetes mellitus (T2DM) in Indian populations is characterized by early onset, progressive beta-cell dysfunction, marked insulin resistance, and a high burden of cardiometabolic comorbidities. While sodium–glucose cotransporter-2 inhibitors and thiazolidinediones offer complementary mechanisms targeting t...